VITASPRING BIOMEDICAL CO. LTD.
vitaspring.comAI Executive Summary
AI-powered analysis of 10-Q filing content
VitaSpring remains a shell-like, non-revenue-generating biomedical company with a severe going concern issue: total liabilities of $4.68 million dwarf total assets of just $14,822, cash on hand is only $13,367, and stockholders' deficit stands at $4,662,229. The company has generated no revenue since FY2022, has an unremediated material weakness in internal controls, and depends entirely on related-party support and future capital raises to survive, with no committed financing in place.
Red Flags Detected (9)
Extreme balance sheet insolvency: $4,677,051 in total liabilities vs. only $14,822 in total assets
Cash balance of just $13,367 is insufficient to fund even minimal operations
No revenue generated for six months ended July 31, 2026, continuing a multi-year revenue drought since FY2022
6 more red flags detected
Key Takeaways
The company remains a going concern with negative equity and minimal liquid assets
No revenue has been generated for over four fiscal years since operations were suspended in FY2022
3 more takeaways
Filing Overview
What This Means
High Risk Filing: This company is showing signs of financial stress or significant operational challenges.
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.